Shareholder Information

 

Shares In Issue

As at 9 August 2021, the number of shares in issue was 87,940,601.

Significant Shareholders

As at 22 April 2021, significant shareholders that hold more than 3% of the share capital of OptiBiotix Health Plc, and shareholdings of any other directors are detailed below:

 NumberOrdinary Shares %
Stephen O'Hara (Director)10,212,98611.61
Finance Yorkshire Seedcorn Fund (FYSCF)9,449,31410.7

Stephen O'Hara holds 6,099,135 shares under Option

Directors' Shareholders

 NumberOrdinary Shares %
Stephen O'Hara (Director)10,212,98611.61
Neil Davidson (Director)503,0000.6
Sean Christie (Director)150,0000.2
Stephen Hammond50,0000.06
Rene Kamminga43,1880.05

 

Shares not in Public hands

In the terms of the AIM Rules and insofar as it is aware, at 9 August 2021, 23.2% of the Company's AIM securities was not in public hands.

Restrictions in transfer of AIM securities

There are no restrictions on the transfer of OptiBiotix Health Plc's AIM securities.

Other exchanges and trading platforms

OptiBiotix Health Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.

Shareholder Circulars

09 July 2021Shareholders Q&As from the AGM held on 09 July 2021
  
17 June 2021Notice of Annual General Meeting held on 09 July 2021
 Proxy for the Annual General Meeting held on 09 July 2021
  
09 July 2020Results of the Proxy votes for the AGM held on 09 July 2020
 Shareholders Q&As from the AGM held on 09 July 2020
  
18 June 2020Notice of Annual General Meeting held on 09 July 2020
 Proxy for the Annual General Meeting held on 09 July 2020
  
17 May 2019Notice of Annual General Meeting held on 11 June 2019
 Proxy for use at the Annual General Meeting held on 11 June 2019
  
11 June 2018Notice of Annual General Meeting held on 4 July 2018
 Proxy for use at the Annual General Meeting held on 4 July 2018
 Proposed New Articles of Association
  
08 January 2018Notice of General Meeting held on 25 January 2018
 Proxy for use at the General Meeting held on 25 January 2018
  
25 April 2017Notice of Annual General Meeting held on 15 June 2017
 Proxy for use at the Annual General Meeting held on 15 June 2017
  
14 April 2016Notice of Annual General Meeting held on 10 May 2016
  
29 May 2015Notice of Annual General Meeting held on 11 August 2015
  
23 July 2014Notice of General Meeting held on 04 August 2014
 Form of Proxy for General Meeting held on 04 August 2014
  
30 January 2014Notice of Annual General Meeting held on 24 February 2014
 Form of Proxy for General Meeting held on 24 February 2014
  
31 November 2013Notice of General Meeting held on 18 November 2013

UK City Code on Takeovers and Mergers

As an AIM traded UK registered company, OptiBiotix Health Plc is subject to the UK City Code on Takeovers and Mergers legislation.

Page last updated: 01 September 2021